DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its target price cut by research analysts at Needham & Company LLC from $25.00 to $23.00 in a research note issued on Friday,Benzinga reports. The firm presently has a "buy" rating on the medical instruments supplier's stock. Needham & Company LLC's price objective suggests a potential upside of 43.84% from the stock's previous close.
A number of other research analysts also recently issued reports on the company. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Tuesday, February 18th. UBS Group dropped their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. Evercore ISI reissued an "in-line" rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Leerink Partnrs downgraded DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday, November 7th. Finally, Wells Fargo & Company started coverage on DENTSPLY SIRONA in a research note on Friday, February 14th. They issued an "equal weight" rating and a $20.00 price objective on the stock. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $23.58.
Read Our Latest Research Report on DENTSPLY SIRONA
DENTSPLY SIRONA Trading Down 3.4 %
Shares of NASDAQ:XRAY traded down $0.56 during midday trading on Friday, reaching $15.99. The company's stock had a trading volume of 4,732,624 shares, compared to its average volume of 2,573,616. The firm has a market capitalization of $3.18 billion, a price-to-earnings ratio of -7.72, a PEG ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a 50 day moving average price of $18.83 and a two-hundred day moving average price of $21.46. DENTSPLY SIRONA has a fifty-two week low of $15.94 and a fifty-two week high of $34.28.
Insiders Place Their Bets
In related news, Director Gregory T. Lucier acquired 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.52% of the company's stock.
Institutional Trading of DENTSPLY SIRONA
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue increased its holdings in DENTSPLY SIRONA by 2.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock worth $637,000 after purchasing an additional 560 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of DENTSPLY SIRONA by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after acquiring an additional 560 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. MML Investors Services LLC grew its holdings in shares of DENTSPLY SIRONA by 2.1% in the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier's stock valued at $803,000 after acquiring an additional 620 shares in the last quarter. Finally, Allworth Financial LP grew its holdings in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock valued at $59,000 after acquiring an additional 625 shares in the last quarter. 95.70% of the stock is owned by institutional investors.
DENTSPLY SIRONA Company Profile
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
